Domachowske Joseph B
Department of Pediatrics, SUNY Upstate Medical University, Syracuse, NY, USA.
Clin Microbiol Newsl. 2004 Oct 15;26(20):155-159. doi: 10.1016/j.clinmicnews.2004.09.004. Epub 2004 Sep 30.
Advances in molecular biology, bioinformatics, and robotics have allowed microarray technology to be used for in-depth, basic science studies in all fields of microbiology. Recently, translation of these basic science applications to clinical microbiology and infectious diseases has also progressed. From a clinical infectious disease perspective, genome-based organism identification, pathogen discovery, and antimicrobial susceptibility testing of problematic organisms offer the potential to yield diagnostic information that may not otherwise become available. Moreover, microarray-based studies have the ability to provide "signatures" of host cell transcriptional responses for individual pathogens and/or groups of pathogens. This type of information has the potential to confirm difficult diagnoses, to monitor responses to therapeutic intervention, or even to predict prognosis and sequelae following an infectious disease. Examples are presented to illustrate ways in which microarray technology has already impacted these areas of clinical microbiology.
分子生物学、生物信息学和机器人技术的进步使微阵列技术能够用于微生物学各个领域的深入基础科学研究。最近,这些基础科学应用向临床微生物学和传染病领域的转化也取得了进展。从临床传染病的角度来看,基于基因组的生物体鉴定、病原体发现以及对疑难生物体的抗菌药敏试验有可能产生其他方式无法获得的诊断信息。此外,基于微阵列的研究有能力为单个病原体和/或病原体群体提供宿主细胞转录反应的“特征”。这类信息有可能确诊疑难病症、监测对治疗干预的反应,甚至预测传染病后的预后和后遗症。文中给出了一些例子来说明微阵列技术已经对临床微生物学的这些领域产生影响的方式。